AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Feb 5, 2020
30071_dirs_2020-02-05_ff58d541-2864-4638-a43f-c9b17d6eb858.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-02-03
Reporting Person: Hollingshead James (President, Sleep Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-03 | ResMed Common Stock | S | 1200 | $159.46 | Disposed | 91974 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
More from RESMED INC
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9